International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines

Highlights • Global collaboration is feasible and enables comparison of vaccine formulations. • Exposure to pandemic H1N1 vaccines was associated with a slight increased risk of GBS. • Adjuvanted vaccines were not associated with higher GBS risk as compared to non-adjuvanted vaccines. • Results from...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:VACCINE 2013-09, Vol.31 (40), p.4448-4458
Hauptverfasser: Dodd, Caitlin N, Romio, Silvana A, Black, Steven, Vellozzi, Claudia, Andrews, Nick, Sturkenboom, Miriam, Zuber, Patrick, Hua, Wei, Bonhoeffer, Jan, Buttery, Jim, Crawford, Nigel, Deceuninck, Genevieve, de Vries, Corinne, De Wals, Philippe, Gimeno, M. Victoria Gutierrez, Heijbel, Harald, Hughes, Hayley, Hur, Kwan, Hviid, Anders, Kelman, Jeffrey, Kilpi, Tehri, Chuang, S.K, Macartney, Kristine, Rett, Melisa, Lopez-Callada, Vesta Richardson, Salmon, Daniel, Sanchez, Francisco Gimenez, Sanz, Nuria, Silverman, Barbara, Storsaeter, Jann, Thirugnanam, Umapathi, van der Maas, Nicoline, Yih, Katherine, Zhang, Tao, Izurieta, Hector
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights • Global collaboration is feasible and enables comparison of vaccine formulations. • Exposure to pandemic H1N1 vaccines was associated with a slight increased risk of GBS. • Adjuvanted vaccines were not associated with higher GBS risk as compared to non-adjuvanted vaccines. • Results from pooled (mega-analytic) and meta-analytic approaches were consistent. • Low relative incidence of GBS supports recommendations for use of influenza vaccines.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2013.06.032